However, as noted by Li et al., PP treatment was toxic to LNCaP cells and AR-negative PC3 cells even at concentrations lower than the AR IC50, which is suggestive that PP’s anti prostate cancer efficacy was mediated through a non-AR-related mechanism [85]. This evidence concerns the gene AR and prostate carcinoma.